General MedicationsTOPICALStandard
MUPIROCIN
MUPIROCIN
Standard Dose
2%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview MUPIROCIN is listed in Drugs@FDA under application 217943 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient MUPIROCIN Form and strength OINTMENT;TOPICAL - 2% Sponsor ENCUBE Submission history Latest submission status date: 2025-05-13 00:00:00.
Structured Monograph
Clinical summary
Approval overview MUPIROCIN is listed in Drugs@FDA under application 217943 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MUPIROCIN Form and strength OINTMENT;TOPICAL - 2% Sponsor ENCUBE Submission history Latest submission status date: 2025-05-13 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.